STOCK TITAN

Broadwood group (NASDAQ: STAA) reports 32.6% STAAR Surgical stake

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13D/A

Rhea-AI Filing Summary

Broadwood Partners, Broadwood Capital and related individuals updated their ownership in STAAR Surgical Company’s common stock. Broadwood Partners and Broadwood Capital each report beneficial ownership of 16,123,842 shares, representing 32.6% of the 49,512,749 shares outstanding. Neal C. Bradsher may be deemed to beneficially own 16,149,742 shares, also 32.6%, through personal holdings and Broadwood Partners, while Richard T. LeBuhn reports 21,286 shares, or 0.0% of the class.

The amendment primarily reflects changes in beneficial ownership percentages and the fact that LeBuhn will cease to be a reporting person following this filing. The group continues to review its investment, may buy or sell shares over time, and remains in contact with management and other shareholders about ways to create additional shareholder value, but discloses no specific current plans for major corporate actions.

Positive

  • None.

Negative

  • None.





If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D




Comment for Type of Reporting Person:
Does not include 2,532 Shares over which Mr. LeBuhn does not have direct or indirect beneficial ownership. Such shares are held in three separate irrevocable trusts for Mr. LeBuhn's daughters in which Mr. LeBuhn has no voting or dispositive power and disclaims any beneficial ownership interest in such shares.


SCHEDULE 13D


Broadwood Partners, L.P.
Signature:/s/ Neal C. Bradsher*
Name/Title:Neal C. Bradsher/President of Broadwood Capital, Inc.
Date:03/13/2026
Broadwood Capital, Inc.
Signature:/s/ Neal C. Bradsher*
Name/Title:Neal C. Bradsher/President
Date:03/13/2026
Neal C. Bradsher
Signature:/s/ Neal C. Bradsher*
Name/Title:Neal C. Bradsher
Date:03/13/2026
Richard T. LeBuhn
Signature:/s/ Richard T. LeBuhn*
Name/Title:Richard T. LeBuhn
Date:03/13/2026
Comments accompanying signature:
* This Reporting Person disclaims beneficial ownership over the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

FAQ

How much of STAAR Surgical (STAA) do the Broadwood entities currently own?

Broadwood Partners, L.P. and Broadwood Capital, Inc. each report beneficial ownership of 16,123,842 STAAR Surgical shares, representing 32.6% of the 49,512,749 shares outstanding as of the filing date, giving the Broadwood group a substantial minority stake.

What is Neal C. Bradsher’s beneficial ownership in STAAR Surgical (STAA)?

Neal C. Bradsher may be deemed to beneficially own 16,149,742 STAAR Surgical shares, or 32.6% of the outstanding stock, combining his 25,900 directly held shares with indirect interests through Broadwood Partners. He holds both voting and dispositive power over these positions.

What change does this Schedule 13D/A Amendment No. 44 report for STAAR Surgical (STAA)?

The amendment reports updated beneficial ownership percentages for the Broadwood reporting persons and clarifies that Richard T. LeBuhn will cease to be a reporting person after this filing, following termination of a prior joint filing and solicitation agreement referenced in the January 16, 2026 amendment.

What is Richard T. LeBuhn’s stake in STAAR Surgical (STAA) after this filing?

Richard T. LeBuhn reports beneficial ownership of 21,286 STAAR Surgical shares, representing 0.0% of the 49,512,749 shares outstanding. This total excludes 2,532 shares held in irrevocable trusts for his daughters, for which he disclaims beneficial ownership.

What intentions do the Broadwood reporting persons state regarding their STAAR Surgical (STAA) investment?

The reporting persons state they will review their investment on a continuing basis and may buy or sell shares in open-market or private transactions. They remain in contact with management and other shareholders about alternatives to create additional shareholder value but list no specific current plans.

Do Broadwood’s representatives hold STAAR Surgical (STAA) stock options, and when do they vest?

As compensation for board service, Neal C. Bradsher and Richard T. LeBuhn hold stock options that vest on the earlier of June 18, 2026 or the company’s 2026 annual meeting of shareholders, subject to their continued service with STAAR Surgical.

How were the funds sourced for Broadwood’s STAAR Surgical (STAA) share purchases?

Broadwood Partners’ 16,123,842 shares were purchased using its working capital, and Broadwood Capital’s beneficial ownership stems from Broadwood Partners’ capital. Neal C. Bradsher used personal funds and Broadwood Partners’ capital, while Richard T. LeBuhn used personal funds; no dedicated borrowing for share purchases is disclosed.
Staar Surg

NASDAQ:STAA

View STAA Stock Overview

STAA Rankings

STAA Latest News

STAA Latest SEC Filings

STAA Stock Data

910.54M
49.44M
Medical Instruments & Supplies
Ophthalmic Goods
Link
United States
MONROVIA